MENU
SCNI
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Scinai Immunotherapeutics (SCNI) Ownership - Who owns Scinai Immunotherapeutics?
Industry: @Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
Hadassah Ein Kerem Campus
Phone
+972 89302529
Employees
33
Web
https://www.biondvax.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.05M
P/E Ratio
N/A
Total Cash
3.08M
Projected Growth
N/A
Total Debt
20.82M
Revenue
284K
Risk (Beta)
2.15
Dividend Yield
N/A
Total Cash/Share
3.67
Total Debt/Equity
N/A
Revenue/Share
0.56 USD as % of share price
Fundamentals
SCNI
Capitalization
3.05M
P/E Ratio
N/A
Risk (Beta)
2.15
Dividend Yield
N/A
Total Cash
3.08M
Total Cash/Share
3.67
Total Debt
20.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.56%
Revenue
284K
ROE
N/A
Book Value
-7.28M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
0
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
2.19
Current Revenue Per Employee
9161.29
Dividends Per Share - Security
N/A
EBITDA
-7M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-21.32
Shares Held By Institutions
56.2K
Shares Outstanding - Current
837K
Total Liabilities
22.1M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-39.200
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of the innovative flu vaccine
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Hadassah Ein Kerem Campus
Phone
+972 89302529
Employees
33
Web
https://www.biondvax.com